NCT00573924View on ClinicalTrials.gov

Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

December 31, 2007

Conditions
Peptic Ulcer Hemorrhage
Interventions
DRUG

Proton pump inhibitor (lansoprazole)

"1. 120 mg PO and then 30 mg PO q 3 h from 3 to 21 hrs~2. 90 mg IV bolus followed 9 mg/hr infusion for 24 hrs"

Trial Locations (1)

90033

L.A. County + U.S.C. Medical Center, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER

NCT00573924 - Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers | Biotech Hunter | Biotech Hunter